Dorian Cohen

Dorian joined Health Advances in 2022 and brings experience in market assessment, opportunity prioritization, and commercial due diligence within the biopharma, diagnostic, and digital health industries.

Prior to joining Health Advances, Dorian was a Corporate Development Analyst at Pear Therapeutics and a Clinical Research Intern at Massachusetts General Hospital, Center for Bipolar Treatment Innovation.

Dorian graduated with a BA in Neuroscience from Bowdoin College.